Begin with a fluorescent-compatible multi-well plate containing a suspension of transgenic mouse-derived T lymphocytes.
These lymphocytes contain a green fluorescent protein or GFP expression cassette, controlled by T cell receptor or TCR engagement with immunomodulatory compounds.
Treat each well with a solution containing immunomodulatory compounds with different potentials.
During incubation, immunomodulatory compounds interact with TCRs on T lymphocytes.
TCR interaction with a stimulating compound triggers the activation of the gene cassette, elevating GFP expression.
In contrast, TCR interaction with an inhibitory compound inhibits the gene cassette and reduces the GFP expression.
Next, overlay the cells with nucleic acid fluorescent dye to stain the nuclei.
Centrifuge the plate to settle the cells for accurate fluorescence measurement.
Under a fluorescence microscope, viable T lymphocytes exhibit two fluorescence signals corresponding to cell nuclei and green fluorescent proteins.
The intensified green fluorescence signifies successful stimulation of T lymphocytes, while a faint intracellular green fluorescence signal confirms the inhibitory effect of immunomodulatory compounds on T lymphocytes.
Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Copyright © 2024 MyJoVE Corporation. All rights reserved